Cbr1 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CBR1 mRNA] | CTD | PMID:31150632 |
Cbr1 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CBR1 mRNA | CTD | PMID:36331819 |
Cbr1 | Rat | 1,2-naphthoquinone | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of 1 and 2-naphthoquinone] | CTD | PMID:23295225 |
Cbr1 | Rat | 1,4-dithiothreitol | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] | CTD | PMID:21256830 |
Cbr1 | Rat | 1,4-naphthoquinone | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1 and 4-naphthoquinone] | CTD | PMID:23295225 |
Cbr1 | Rat | 13-dihydrodaunorubicin | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [[Curcumin binds to and results in decreased activity of CBR1 protein] which results in decreased reduction of Daunorubicin] which results in decreased chemical synthesis of daunorubicinol more ... | CTD | PMID:20670211 and PMID:25541467 |
Cbr1 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Cbr1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of CBR1 mRNA | CTD | PMID:17555576 |
Cbr1 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of CBR1 mRNA | CTD | PMID:17942748 |
Cbr1 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBR1 mRNA | CTD | PMID:17942748 |
Cbr1 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of CBR1 mRNA | CTD | PMID:26496021 |
Cbr1 | Rat | 17beta-estradiol | decreases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Estradiol results in decreased expression of CBR1 mRNA | CTD | PMID:39298647 |
Cbr1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CBR1 mRNA | CTD | PMID:22298810 |
Cbr1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CBR1 mRNA | CTD | PMID:18796159 and PMID:19933214 |
Cbr1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cbr1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CBR1 mRNA | CTD | PMID:20702594 and PMID:21570461 |
Cbr1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CBR1 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBR1 mRNA | CTD | PMID:16214954 and PMID:17942748 |
Cbr1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CBR1 protein | CTD | PMID:19492234 |
Cbr1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CBR1 mRNA | CTD | PMID:33387578 |
Cbr1 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of CBR1 mRNA | CTD | PMID:21346803 |
Cbr1 | Rat | 2,6-dimethoxyphenol | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [pyrogallol 1 more ... | CTD | PMID:38598786 |
Cbr1 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of CBR1 mRNA | CTD | PMID:21346803 |
Cbr1 | Rat | 2-acetamidofluorene | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | 2-Acetylaminofluorene results in increased expression of CBR1 mRNA | CTD | PMID:21607683 |
Cbr1 | Rat | 2-amino-14,16-dimethyloctadecan-3-ol | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | 2-amino-14 and 16-dimethyloctadecan-3-ol results in decreased expression of CBR1 protein | CTD | PMID:32044396 |
Cbr1 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of CBR1 mRNA | CTD | PMID:30851411 |
Cbr1 | Rat | 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of CBR1 protein | CTD | PMID:15928459 |
Cbr1 | Rat | 3,3',4,4',5-pentachlorobiphenyl | affects expression | ISO | Cbr1 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:20702594 |
Cbr1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of CBR1 mRNA | CTD | PMID:39298647 |
Cbr1 | Rat | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases metabolic processing | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CTD | PMID:11306090 |
Cbr1 | Rat | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] more ... | CTD | PMID:11306090 |
Cbr1 | Rat | 4-amino-2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of CBR1 mRNA | CTD | PMID:21346803 |
Cbr1 | Rat | 4-Benzoylpyridine | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 4-benzoylpyridine] | CTD | PMID:23295225 |
Cbr1 | Rat | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of CBR1 mRNA | CTD | PMID:19483382 |
Cbr1 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of CBR1 mRNA | CTD | PMID:24780913 and PMID:30047161 |
Cbr1 | Rat | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of CBR1 mRNA | CTD | PMID:19483382 |
Cbr1 | Rat | 9,10-phenanthroquinone | increases metabolic processing | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased metabolism of 9 and 10-phenanthrenequinone | CTD | PMID:29108775 |
Cbr1 | Rat | 9,10-phenanthroquinone | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... | CTD | PMID:21910479 and PMID:23295225 |
Cbr1 | Rat | actinomycin D | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of CBR1 protein | CTD | PMID:38460933 |
Cbr1 | Rat | Aloe emodin | decreases activity | ISO | CBR1 (Homo sapiens) | 6480464 | aloe emodin results in decreased activity of CBR1 protein | CTD | PMID:35065925 |
Cbr1 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CBR1 mRNA | CTD | PMID:35163327 |
Cbr1 | Rat | amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of CBR1 mRNA | CTD | PMID:19483382 |
Cbr1 | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of CBR1 mRNA | CTD | PMID:30047161 |
Cbr1 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CBR1 mRNA | CTD | PMID:16483693 |
Cbr1 | Rat | andrographolide | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA | CTD | PMID:19737545 |
Cbr1 | Rat | antimonite | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA | CTD | PMID:32076005 |
Cbr1 | Rat | antimycin A | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Antimycin A results in decreased expression of CBR1 mRNA | CTD | PMID:33512557 |
Cbr1 | Rat | aristolochic acid A | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of CBR1 protein | CTD | PMID:33212167 |
Cbr1 | Rat | arsane | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CBR1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CBR1 mRNA | CTD | PMID:39836092 |
Cbr1 | Rat | arsenic atom | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CBR1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CBR1 mRNA | CTD | PMID:39836092 |
Cbr1 | Rat | arsenite(3-) | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in increased expression of CBR1 mRNA more ... | CTD | PMID:32076005 and PMID:32406909 |
Cbr1 | Rat | arsenous acid | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CBR1 mRNA | CTD | PMID:22719067 |
Cbr1 | Rat | arsenous acid | decreases response to substance | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:22719067 |
Cbr1 | Rat | atrazine | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of CBR1 mRNA | CTD | PMID:22378314 |
Cbr1 | Rat | benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of CBR1 mRNA | CTD | PMID:19483382 |
Cbr1 | Rat | benzo[a]pyrene | decreases methylation | ISO | CBR1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of CBR1 exon | CTD | PMID:27901495 |
Cbr1 | Rat | benzo[a]pyrene | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CBR1 mRNA and Benzo(a)pyrene results in increased expression of CBR1 protein | CTD | PMID:22531821 |
Cbr1 | Rat | benzo[a]pyrene | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [lipopolysaccharide and E coli O55-B5 co-treated with Benzo(a)pyrene] affects the expression of CBR1 mRNA | CTD | PMID:28987381 |
Cbr1 | Rat | benzo[a]pyrene | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CBR1 mRNA | CTD | PMID:19770486 more ... |
Cbr1 | Rat | beta-naphthoflavone | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA | CTD | PMID:19737545 |
Cbr1 | Rat | beta-naphthoflavone | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of CBR1 mRNA | CTD | PMID:17569794 and PMID:19737606 |
Cbr1 | Rat | bexarotene | increases expression | EXP | | 6480464 | Bexarotene results in increased expression of CBR1 mRNA | CTD | PMID:16648578 |
Cbr1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CBR1 mRNA | CTD | PMID:25181051 |
Cbr1 | Rat | bisphenol A | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CBR1 protein | CTD | PMID:37567409 |
Cbr1 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of CBR1 mRNA and [bisphenol A co-treated with Testosterone] results in increased expression of CBR1 mRNA | CTD | PMID:26496021 |
Cbr1 | Rat | bisphenol AF | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of CBR1 protein | CTD | PMID:34186270 |
Cbr1 | Rat | Bisphenol B | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of CBR1 protein | CTD | PMID:34186270 |
Cbr1 | Rat | bisphenol F | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of CBR1 protein | CTD | PMID:34186270 |
Cbr1 | Rat | butylated hydroxyanisole | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Butylated Hydroxyanisole results in increased expression of CBR1 mRNA and Butylated Hydroxyanisole results in increased expression of CBR1 protein | CTD | PMID:23247010 |
Cbr1 | Rat | captan | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Captan results in increased expression of CBR1 mRNA | CTD | PMID:31558096 |
Cbr1 | Rat | carbamazepine | affects expression | ISO | CBR1 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of CBR1 mRNA | CTD | PMID:24752500 |
Cbr1 | Rat | carbon nanotube | decreases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 |
Cbr1 | Rat | CGP 52608 | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CBR1 gene] | CTD | PMID:28238834 |
Cbr1 | Rat | chenodeoxycholic acid | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA | CTD | PMID:32152650 |
Cbr1 | Rat | chloroprene | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Chloroprene results in increased expression of CBR1 mRNA | CTD | PMID:23125180 |
Cbr1 | Rat | ciprofibrate | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | ciprofibrate results in increased expression of CBR1 mRNA | CTD | PMID:12771043 |
Cbr1 | Rat | cisplatin | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of CBR1 mRNA | CTD | PMID:27392435 |
Cbr1 | Rat | clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of CBR1 mRNA | CTD | PMID:19483382 |
Cbr1 | Rat | Clofop | increases reduction | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased reduction of fenofibric acid | CTD | PMID:27599626 |
Cbr1 | Rat | coumarin | increases expression | EXP | | 6480464 | coumarin results in increased expression of CBR1 mRNA | CTD | PMID:18480146 |
Cbr1 | Rat | coumestrol | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of CBR1 mRNA | CTD | PMID:19167446 |
Cbr1 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of CBR1 mRNA | CTD | PMID:26577399 |
Cbr1 | Rat | curcumin | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [[Curcumin binds to and results in decreased activity of CBR1 protein] which results in decreased reduction of Daunorubicin] which results in decreased chemical synthesis of daunorubicinol more ... | CTD | PMID:25541467 |
Cbr1 | Rat | cyclosporin A | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CBR1 mRNA | CTD | PMID:20106945 and PMID:25562108 |
Cbr1 | Rat | cyclosporin A | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA | CTD | PMID:32152650 |
Cbr1 | Rat | cyclosporin A | decreases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of CBR1 mRNA | CTD | PMID:19770486 |
Cbr1 | Rat | daunorubicin | decreases metabolic processing | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 gene SNP results in decreased metabolism of Daunorubicin | CTD | PMID:19204081 |
Cbr1 | Rat | daunorubicin | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... | CTD | PMID:20670211 more ... |
Cbr1 | Rat | daunorubicin | increases reduction | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased reduction of Daunorubicin | CTD | PMID:18579125 and PMID:25541467 |
Cbr1 | Rat | daunorubicin | increases metabolic processing | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased metabolism of Daunorubicin and CBR1 results in increased metabolism of Daunorubicin | CTD | PMID:20670211 and PMID:30849340 |
Cbr1 | Rat | deguelin | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | deguelin results in decreased expression of CBR1 mRNA | CTD | PMID:33512557 |
Cbr1 | Rat | deoxycholic acid | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA | CTD | PMID:32152650 |
Cbr1 | Rat | dexamethasone | decreases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Dexamethasone results in decreased expression of CBR1 mRNA | CTD | PMID:22733784 |
Cbr1 | Rat | dextran sulfate | decreases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Dextran Sulfate results in decreased expression of CBR1 protein | CTD | PMID:35999755 |
Cbr1 | Rat | diarsenic trioxide | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CBR1 mRNA | CTD | PMID:22719067 |
Cbr1 | Rat | diarsenic trioxide | decreases response to substance | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:22719067 |
Cbr1 | Rat | dibenzofurans | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Dibenzofurans results in increased expression of CBR1 mRNA | CTD | PMID:34254344 |
Cbr1 | Rat | Dibutyl phosphate | affects expression | ISO | CBR1 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CBR1 mRNA | CTD | PMID:37042841 |
Cbr1 | Rat | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CBR1 mRNA | CTD | PMID:21266533 |
Cbr1 | Rat | dibutyl phthalate | decreases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of CBR1 mRNA | CTD | PMID:17361019 and PMID:21266533 |
Cbr1 | Rat | diclofenac | affects expression | ISO | CBR1 (Homo sapiens) | 6480464 | Diclofenac affects the expression of CBR1 mRNA | CTD | PMID:24752500 |
Cbr1 | Rat | diethyl maleate | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | diethyl maleate results in increased expression of CBR1 mRNA | CTD | PMID:25270620 |
Cbr1 | Rat | dioxygen | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | 3 more ... | CTD | PMID:24975222 |
Cbr1 | Rat | dioxygen | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBR1 mRNA | CTD | PMID:30529165 |
Cbr1 | Rat | dioxygen | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of CBR1 mRNA and Oxygen deficiency results in increased expression of CBR1 protein | CTD | PMID:24975222 |
Cbr1 | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA | CTD | PMID:32076005 |
Cbr1 | Rat | diquat | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Diquat results in increased expression of CBR1 mRNA | CTD | PMID:36851058 |
Cbr1 | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of CBR1 mRNA | CTD | PMID:21551480 |
Cbr1 | Rat | dorsomorphin | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA | CTD | PMID:27188386 |
Cbr1 | Rat | doxorubicin | affects reduction | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein affects the reduction of Doxorubicin | CTD | PMID:18635746 |
Cbr1 | Rat | doxorubicin | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of CBR1 protein | CTD | PMID:18755171 |
Cbr1 | Rat | doxorubicin | increases reduction | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased reduction of Doxorubicin | CTD | PMID:18755171 |
Cbr1 | Rat | doxorubicin | decreases metabolic processing | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 gene SNP results in decreased metabolism of Doxorubicin | CTD | PMID:19204081 |
Cbr1 | Rat | doxorubicin | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin | CTD | PMID:24064738 |
Cbr1 | Rat | doxorubicin | increases response to substance | ISO | Cbr1 (Mus musculus) | 6480464 | CBR1 protein results in increased susceptibility to Doxorubicin | CTD | PMID:11016643 and PMID:14583452 |
Cbr1 | Rat | emodin | decreases activity | ISO | CBR1 (Homo sapiens) | 6480464 | Emodin results in decreased activity of CBR1 protein | CTD | PMID:35065925 |
Cbr1 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of CBR1 mRNA | CTD | PMID:29391264 |
Cbr1 | Rat | etacrynic acid | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] | CTD | PMID:11306090 |
Cbr1 | Rat | ethanol | affects expression | ISO | Cbr1 (Mus musculus) | 6480464 | Ethanol affects the expression of CBR1 mRNA | CTD | PMID:30319688 |
Cbr1 | Rat | ethanol | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Ethanol results in increased expression of CBR1 mRNA | CTD | PMID:30319688 |
Cbr1 | Rat | fenpyroximate | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | fenpyroximate results in decreased expression of CBR1 mRNA | CTD | PMID:33512557 |
Cbr1 | Rat | fenthion | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Fenthion results in increased expression of CBR1 mRNA | CTD | PMID:34813904 |
Cbr1 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of CBR1 mRNA | CTD | PMID:24136188 |
Cbr1 | Rat | folpet | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | folpet results in increased expression of CBR1 mRNA | CTD | PMID:31558096 |
Cbr1 | Rat | FR900359 | increases phosphorylation | ISO | CBR1 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of CBR1 protein | CTD | PMID:37730182 |
Cbr1 | Rat | Frangulin A | decreases activity | ISO | CBR1 (Homo sapiens) | 6480464 | frangulin A results in decreased activity of CBR1 protein | CTD | PMID:35065925 |
Cbr1 | Rat | Frangulin B | decreases activity | ISO | CBR1 (Homo sapiens) | 6480464 | frangulin B results in decreased activity of CBR1 protein | CTD | PMID:35065925 |
Cbr1 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of CBR1 mRNA | CTD | PMID:25539665 |
Cbr1 | Rat | furan | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | furan results in increased expression of CBR1 mRNA | CTD | PMID:24183702 |
Cbr1 | Rat | furfural | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [pyrogallol 1 and 3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of CBR1 protein | CTD | PMID:38598786 |
Cbr1 | Rat | genistein | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Genistein results in increased expression of CBR1 mRNA | CTD | PMID:34942354 |
Cbr1 | Rat | genistein | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Genistein co-treated with NADP] binds to CBR1 protein | CTD | PMID:25526675 |
Cbr1 | Rat | genistein | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of CBR1 mRNA | CTD | PMID:34942354 |
Cbr1 | Rat | genistein | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Genistein results in increased expression of CBR1 mRNA | CTD | PMID:16705744 |
Cbr1 | Rat | glycochenodeoxycholic acid | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA | CTD | PMID:32152650 |
Cbr1 | Rat | glycocholic acid | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA | CTD | PMID:32152650 |
Cbr1 | Rat | glycodeoxycholic acid | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA | CTD | PMID:32152650 |
Cbr1 | Rat | griseofulvin | affects expression | ISO | Cbr1 (Mus musculus) | 6480464 | Griseofulvin affects the expression of CBR1 mRNA | CTD | PMID:12735108 |
Cbr1 | Rat | hexane-2,3-dione | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased reduction of 2 more ... | CTD | PMID:23295225 more ... |
Cbr1 | Rat | hexane-2,3-dione | increases reduction | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased reduction of 2 and 3-hexanedione | CTD | PMID:25541467 and PMID:30849340 |
Cbr1 | Rat | hydrazine | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | hydrazine results in increased expression of CBR1 mRNA | CTD | PMID:15282401 |
Cbr1 | Rat | indometacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of CBR1 mRNA | CTD | PMID:18299717 |
Cbr1 | Rat | inulin | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CBR1 mRNA | CTD | PMID:36331819 |
Cbr1 | Rat | isatin | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of Isatin] | CTD | PMID:23295225 |
Cbr1 | Rat | Isoxanthohumol | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | isoxanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... | CTD | PMID:30849340 |
Cbr1 | Rat | Isoxanthohumol | decreases activity | ISO | CBR1 (Homo sapiens) | 6480464 | isoxanthohumol results in decreased activity of CBR1 protein | CTD | PMID:35065925 |
Cbr1 | Rat | ivermectin | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CBR1 protein | CTD | PMID:32959892 |
Cbr1 | Rat | L-1,4-dithiothreitol | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] | CTD | PMID:21256830 |
Cbr1 | Rat | L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of CBR1 mRNA | CTD | PMID:19483382 |
Cbr1 | Rat | lead diacetate | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | lead acetate results in increased expression of CBR1 mRNA | CTD | PMID:38568856 |
Cbr1 | Rat | leflunomide | increases expression | EXP | | 6480464 | Leflunomide results in increased expression of CBR1 mRNA | CTD | PMID:24136188 |
Cbr1 | Rat | lipopolysaccharide | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein modified form inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] more ... | CTD | PMID:25818598 |
Cbr1 | Rat | m-xylene | increases expression | EXP | | 6480464 | 3-xylene results in increased expression of CBR1 mRNA | CTD | PMID:12815608 |
Cbr1 | Rat | manganese atom | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CBR1 mRNA | CTD | PMID:39836092 |
Cbr1 | Rat | manganese(0) | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CBR1 mRNA | CTD | PMID:39836092 |
Cbr1 | Rat | manganese(II) chloride | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CBR1 mRNA | CTD | PMID:39836092 |
Cbr1 | Rat | menadione | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of Vitamin K 3] and Vitamin K 3 inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] | CTD | PMID:11306090 and PMID:23295225 |
Cbr1 | Rat | menadione | increases metabolic processing | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased metabolism of Vitamin K 3 | CTD | PMID:19061875 |
Cbr1 | Rat | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of CBR1 mRNA | CTD | PMID:15644446 |
Cbr1 | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of CBR1 mRNA | CTD | PMID:30047161 |
Cbr1 | Rat | methylmercury chloride | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CBR1 mRNA | CTD | PMID:27188386 |
Cbr1 | Rat | microcystin-LR | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of CBR1 mRNA | CTD | PMID:17654400 |
Cbr1 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of CBR1 mRNA | CTD | PMID:34942354 |
Cbr1 | Rat | monosodium L-glutamate | increases activity | ISO | Cbr1 (Mus musculus) | 6480464 | Sodium Glutamate results in increased activity of CBR1 protein | CTD | PMID:25473020 |
Cbr1 | Rat | N-methyl-N-nitrosourea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of CBR1 mRNA | CTD | PMID:16525678 |
Cbr1 | Rat | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of CBR1 mRNA | CTD | PMID:19638242 |
Cbr1 | Rat | N-nitrosodiethylamine | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of CBR1 mRNA | CTD | PMID:12771043 and PMID:21607683 |
Cbr1 | Rat | N-nitrosomorpholine | increases expression | EXP | | 6480464 | N-nitrosomorpholine results in increased expression of CBR1 mRNA | CTD | PMID:19716841 |
Cbr1 | Rat | NADP zwitterion | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... | CTD | PMID:21910479 more ... |
Cbr1 | Rat | NADP(+) | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... | CTD | PMID:21910479 more ... |
Cbr1 | Rat | naphthalenes | increases expression | EXP | | 6480464 | Naphthalenes results in increased expression of CBR1 protein | CTD | PMID:17337753 |
Cbr1 | Rat | naphthalenes | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of Naphthalenes | CTD | PMID:21910479 |
Cbr1 | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of CBR1 mRNA | CTD | PMID:24136188 |
Cbr1 | Rat | nefazodone | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA | CTD | PMID:32152650 |
Cbr1 | Rat | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of CBR1 mRNA | CTD | PMID:24136188 |
Cbr1 | Rat | Nutlin-3 | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of CBR1 protein | CTD | PMID:38460933 |
Cbr1 | Rat | omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of CBR1 mRNA | CTD | PMID:19483382 |
Cbr1 | Rat | oxcarbazepine | increases reduction | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased reduction of Oxcarbazepine | CTD | PMID:25063510 |
Cbr1 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CBR1 mRNA | CTD | PMID:18246545 |
Cbr1 | Rat | paracetamol | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CBR1 mRNA | CTD | PMID:22230336 and PMID:29067470 |
Cbr1 | Rat | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CBR1 mRNA | CTD | PMID:18246545 |
Cbr1 | Rat | parathion | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Parathion results in increased expression of CBR1 mRNA | CTD | PMID:34813904 |
Cbr1 | Rat | pentachlorophenol | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of CBR1 mRNA | CTD | PMID:23892564 |
Cbr1 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of CBR1 mRNA | CTD | PMID:37995155 |
Cbr1 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CBR1 mRNA more ... | CTD | PMID:36331819 |
Cbr1 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CBR1 mRNA | CTD | PMID:35163327 |
Cbr1 | Rat | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of CBR1 mRNA | CTD | PMID:19162173 |
Cbr1 | Rat | phenobarbital | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Phenobarbital results in decreased expression of CBR1 protein | CTD | PMID:35881160 |
Cbr1 | Rat | phenobarbital | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of CBR1 mRNA and Phenobarbital results in increased expression of CBR1 protein | CTD | PMID:19482888 more ... |
Cbr1 | Rat | phenobarbital | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CBR1 mRNA] | CTD | PMID:19482888 |
Cbr1 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein modified form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1B mRNA] more ... | CTD | PMID:25818598 |
Cbr1 | Rat | phorone | affects expression | EXP | | 6480464 | phorone affects the expression of CBR1 mRNA | CTD | PMID:18198479 |
Cbr1 | Rat | pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of CBR1 mRNA | CTD | PMID:19483382 |
Cbr1 | Rat | pirinixic acid | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CBR1 mRNA and PPARA protein promotes the reaction [pirinixic acid results in increased expression of CBR1 mRNA] | CTD | PMID:19710929 and PMID:20059764 |
Cbr1 | Rat | pirinixic acid | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CBR1 mRNA | CTD | PMID:18301758 more ... |
Cbr1 | Rat | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CBR1 mRNA | CTD | PMID:19162173 and PMID:22484513 |
Cbr1 | Rat | potassium chromate | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of CBR1 mRNA | CTD | PMID:22714537 |
Cbr1 | Rat | propiconazole | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | propiconazole results in increased expression of CBR1 mRNA | CTD | PMID:21278054 |
Cbr1 | Rat | quercetin | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Quercetin co-treated with NADP] binds to CBR1 protein more ... | CTD | PMID:11306090 more ... |
Cbr1 | Rat | rac-lactic acid | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of CBR1 mRNA | CTD | PMID:30851411 |
Cbr1 | Rat | Rebamipide | increases expression | EXP | | 6480464 | rebamipide results in increased expression of CBR1 mRNA | CTD | PMID:18299717 |
Cbr1 | Rat | resveratrol | affects binding | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein binds to Resveratrol | CTD | PMID:24064738 |
Cbr1 | Rat | resveratrol | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin more ... | CTD | PMID:24064738 and PMID:24975222 |
Cbr1 | Rat | resveratrol | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CBR1 mRNA] | CTD | PMID:31298478 |
Cbr1 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of CBR1 mRNA | CTD | PMID:28374803 |
Cbr1 | Rat | rutin | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | Rutin binds to and results in decreased activity of CBR1 protein and Rutin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] | CTD | PMID:11306090 and PMID:18579125 |
Cbr1 | Rat | S-nitrosoglutathione | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1 more ... | CTD | PMID:21256830 and PMID:23295225 |
Cbr1 | Rat | S-nitrosoglutathione | increases reduction | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased reduction of S-Nitrosoglutathione | CTD | PMID:21256830 |
Cbr1 | Rat | SB 431542 | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 |
Cbr1 | Rat | sodium arsenite | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CBR1 mRNA | CTD | PMID:38568856 |
Cbr1 | Rat | sodium arsenite | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of CBR1 mRNA | CTD | PMID:28595984 and PMID:34032870 |
Cbr1 | Rat | sodium arsenite | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CBR1 mRNA more ... | CTD | PMID:32076005 and PMID:39836092 |
Cbr1 | Rat | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of CBR1 protein | CTD | PMID:29459688 |
Cbr1 | Rat | sodium chloride | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with pyrogallol 1 and 3-dimethyl ether] results in decreased expression of and affects the localization of CBR1 protein | CTD | PMID:38598786 |
Cbr1 | Rat | sodium dichromate | decreases expression | ISO | Cbr1 (Mus musculus) | 6480464 | sodium bichromate results in decreased expression of CBR1 mRNA | CTD | PMID:22155349 |
Cbr1 | Rat | sophoraflavanone B | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... | CTD | PMID:30849340 |
Cbr1 | Rat | streptozocin | decreases activity | EXP | | 6480464 | Streptozocin results in decreased activity of CBR1 protein | CTD | PMID:11057757 |
Cbr1 | Rat | sulfasalazine | decreases expression | EXP | | 6480464 | Sulfasalazine results in decreased expression of CBR1 protein | CTD | PMID:15928459 |
Cbr1 | Rat | T-2 toxin | affects expression | EXP | | 6480464 | T-2 Toxin affects the expression of CBR1 protein | CTD | PMID:26141394 |
Cbr1 | Rat | tebufenpyrad | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of CBR1 mRNA | CTD | PMID:33512557 |
Cbr1 | Rat | testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of CBR1 mRNA | CTD | PMID:26496021 |
Cbr1 | Rat | testosterone enanthate | affects expression | ISO | CBR1 (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of CBR1 mRNA | CTD | PMID:17440010 |
Cbr1 | Rat | tetrachloroethene | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of CBR1 mRNA | CTD | PMID:28973375 |
Cbr1 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CBR1 mRNA | CTD | PMID:30723492 and PMID:31150632 |
Cbr1 | Rat | tetrachloromethane | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CBR1 mRNA | CTD | PMID:27339419 |
Cbr1 | Rat | tetrachloromethane | affects expression | ISO | Cbr1 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of CBR1 mRNA | CTD | PMID:31919559 |
Cbr1 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CBR1 mRNA] | CTD | PMID:31150632 |
Cbr1 | Rat | thalidomide | decreases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Thalidomide results in decreased expression of CBR1 mRNA | CTD | PMID:26217789 |
Cbr1 | Rat | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of CBR1 protein | CTD | PMID:35544339 |
Cbr1 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CBR1 mRNA | CTD | PMID:23411599 and PMID:34492290 |
Cbr1 | Rat | thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of CBR1 mRNA | CTD | PMID:19483382 |
Cbr1 | Rat | tiaprofenic acid | increases reduction | ISO | CBR1 (Homo sapiens) | 6480464 | CBR1 protein results in increased reduction of tiaprofenic acid | CTD | PMID:28322780 |
Cbr1 | Rat | titanium dioxide | decreases methylation | ISO | Cbr1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CBR1 gene | CTD | PMID:35295148 |
Cbr1 | Rat | titanium dioxide | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CBR1 mRNA | CTD | PMID:23131501 and PMID:31298478 |
Cbr1 | Rat | titanium dioxide | multiple interactions | ISO | Cbr1 (Mus musculus) | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CBR1 mRNA] | CTD | PMID:31298478 |
Cbr1 | Rat | triclosan | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [Triclosan co-treated with NADP] binds to CBR1 protein | CTD | PMID:25526675 |
Cbr1 | Rat | undecane | increases expression | EXP | | 6480464 | undecane results in increased expression of CBR1 protein | CTD | PMID:17337753 |
Cbr1 | Rat | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of CBR1 mRNA | CTD | PMID:24136188 |
Cbr1 | Rat | valproic acid | decreases methylation | ISO | CBR1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of CBR1 gene | CTD | PMID:29154799 |
Cbr1 | Rat | valproic acid | increases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CBR1 mRNA | CTD | PMID:23179753 more ... |
Cbr1 | Rat | valproic acid | affects expression | ISO | CBR1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CBR1 mRNA | CTD | PMID:25979313 |
Cbr1 | Rat | valproic acid | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA | CTD | PMID:27188386 |
Cbr1 | Rat | valproic acid | affects expression | ISO | Cbr1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of CBR1 mRNA | CTD | PMID:17292431 |
Cbr1 | Rat | vancomycin | increases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Vancomycin results in increased expression of CBR1 mRNA | CTD | PMID:18930951 |
Cbr1 | Rat | xanthohumol | multiple interactions | ISO | CBR1 (Homo sapiens) | 6480464 | xanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... | CTD | PMID:30849340 |
Cbr1 | Rat | zearalenone | decreases expression | ISO | Cbr1 (Mus musculus) | 6480464 | Zearalenone results in decreased expression of CBR1 protein | CTD | PMID:36252740 |
Cbr1 | Rat | zoledronic acid | decreases expression | ISO | CBR1 (Homo sapiens) | 6480464 | Zoledronic Acid results in decreased expression of CBR1 mRNA | CTD | PMID:24714768 |